NCT00154466

Brief Summary

One emerging concept is that some form of injury or inflammation is a prerequisite for the success of circulating-cell participation in differentiated tissue structure and function. Once reperfusion is achieved in acute myocardial infarction, an intense inflammatory cascade is unleashed. The architecture of the left ventricle rearranges, leading to ventricular remodeling. The "homing process"involves stem cell migration to the sites of injury or ischemia, which provides an environment that is favorable to growth and function. This microenvironment is a stimulus for homing and differentiation of stem cells of the appropriate lineage. It increases vascular permeability and expression of adhesion proteins like integrin, along with homing receptors that facilitate the attachment, which is mediated by cell-to-cell contact and chemoattractant release from local tissue injury.The migratory capacity of stem cells might be dependent on natural growth factors such as vascular endothelial growth factor (VEGF) , stromal cell-derived factor-1 (SDF-1)and stem cell factor (SCF).The expression of VEGF ,SDF-1 and SCF is highly up-regulated in hypoxic tissue, supporting the hypothesis that these factors may represent homing signals crucial to the recruitment of circulating progenitor cells to assist the endogenous repair mechanisms in the infarcted tissue. This study will examine whether cardiac rehabilitation increases the concentration of stem cell factors released into the bloodstream and if these factors are correlated with the improvement of heart function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2004

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2004

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

September 9, 2005

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 12, 2005

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
2.6 years until next milestone

Results Posted

Study results publicly available

June 26, 2014

Completed
Last Updated

June 26, 2014

Status Verified

May 1, 2014

Enrollment Period

6 years

First QC Date

September 9, 2005

Results QC Date

December 6, 2012

Last Update Submit

May 25, 2014

Conditions

Keywords

Myocardial infarction, stem cell, cardiac rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Myocardial Blood Flow at Baseline and 3-month Follow-up

    First-pass, contrast-enhanced myocardial perfusion images acquired for 80 heart beats in the left ventricle. Short-axis views were obtained after intravenous administration of gadodiamide. Perfusion studies were performed at rest and during the stress induced by a 4 min infusion of dipyridamole at a concentration of 0.14 mg/kg of body weight per minute.To determine absolute MBF values at rest and stress status, we adopted a model-independent deconvolution method proposed by Jerosch-Herold et al, a method that was previously validated in experimental animal studies by comparison with blood-flow measurements with radiolabelled microspheres.

    3 months

Secondary Outcomes (1)

  • Angiogenic Cytokines at Baseline and 3-month Follow-up

    3 months

Study Arms (3)

cardiac rehabilitation

EXPERIMENTAL

Those in the training group participated in a 3-month rehabilitation training program at an exercise intensity of 55% to 70% of peak oxygen uptake (VO2.

Behavioral: cardiac rehabilitation

postinfarction patients

NO INTERVENTION

those in the nontraining group continued their usual lifestyle

healthy controls

PLACEBO COMPARATOR

Age-, weight-, and height-matched subjects without cardiovascular risk factors were selected as healthy controls.

Interventions

Those in the training group participated in a 3-month rehabilitation training program at an exercise intensity of 55% to 70% of peak oxygen uptake (VO2); those in the nontraining group continued their usual lifestyle.

Also known as: exercise training
cardiac rehabilitation

Eligibility Criteria

Age35 Years - 65 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

Related Publications (1)

  • Lee BC, Hsu HC, Tseng WY, Su MY, Chen SY, Wu YW, Chien KL, Chen MF. Effect of cardiac rehabilitation on angiogenic cytokines in postinfarction patients. Heart. 2009 Jun;95(12):1012-8. doi: 10.1136/hrt.2008.153510. Epub 2009 Mar 19.

MeSH Terms

Conditions

Myocardial Infarction

Interventions

Cardiac RehabilitationExercise

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Limitations and Caveats

First, our trial is small size. Second, these results are applicable only for male patients less than 65 years old with ST-segment elevation MI after successful PCI. Third, the source of angiogenic cytokines cannot be elucidated.

Results Point of Contact

Title
Dr. Bai-Chin Lee
Organization
National Taiwan University Hospital

Study Officials

  • Bai-Chin Lee, MD

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR
  • Ssu-Yuan Chen, MD

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR
  • Wen-Yih Tseng, MD, PhD

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR
  • Ming-Fong Chen, MD, PhD

    National Taiwan University Hospital

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2005

First Posted

September 12, 2005

Study Start

July 1, 2004

Primary Completion

July 1, 2010

Study Completion

December 1, 2011

Last Updated

June 26, 2014

Results First Posted

June 26, 2014

Record last verified: 2014-05

Locations